Li Hui-Shan, Singh Bijay, Park Tae-Eun, Hong Zhong-Shan, Kang Sang-Kee, Cho Chong-Su, Choi Yun-Jaie
Department of Agricultural Biotechnology & Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul 151-921, South Korea.
Department of Animal Science, Tianjin Agricultural University, Tianjin 300-384, China.
Eur J Pharm Sci. 2015 Dec 1;80:16-25. doi: 10.1016/j.ejps.2015.09.014. Epub 2015 Sep 28.
Mucosal vaccination of protein as an antigen requires appropriate delivery or adjuvant systems to deliver antigen to mucosal immune cells efficiently and generate valid immune responses. For successful nasal immunization, the obstacles imposed by the normal process of mucociliary clearance which limits residence time of applied antigens and low antigen delivery to antigen presenting cells (APCs) in nasal associated lymphoid tissue (NALT) need to be overcome for the efficient vaccination. Here, we prepared mucoadhesive and mannan-decorated thiolated Eudragit microspheres (Man-TEM) as a nasal vaccine carrier to overcome the limitations. Mucoadhesive thiolated Eudragit (TE) were decorated with mannan for targeting mannose receptors (MR) in antigen presenting cells (APCs) to obtain efficient immune responses. The potential adjuvant ability of Man-TEM for intranasal immunization was confirmed by in vitro and in vivo experiments. In mechanistic study using APCs in vitro, we obtained that Man-TEM enhanced the receptor-mediated endocytosis by stimulating the MR receptors of APCs. The nasal vaccination of OVA-loaded Man-TEM in mice showed higher levels of serum IgG and mucosal sIgA than the soluble OVA group due to the specific recognition of MR of APCs by the mannan in the Man-TEM. These results suggest that mucoadhesive and Man-TEM may be a promising candidate for nasal vaccine delivery system to elicit systemic and mucosal immunity.
将蛋白质作为抗原进行黏膜疫苗接种需要合适的递送或佐剂系统,以便有效地将抗原递送至黏膜免疫细胞并产生有效的免疫反应。为了成功进行鼻腔免疫,需要克服黏液纤毛清除正常过程所带来的障碍,该过程限制了所应用抗原的停留时间,并且抗原递送至鼻相关淋巴组织(NALT)中的抗原呈递细胞(APC)的效率较低,以实现有效的疫苗接种。在此,我们制备了黏附性且经甘露聚糖修饰的巯基化Eudragit微球(Man-TEM)作为鼻腔疫苗载体,以克服这些限制。将黏附性巯基化Eudragit(TE)用甘露聚糖修饰,以靶向抗原呈递细胞(APC)中的甘露糖受体(MR),从而获得有效的免疫反应。通过体外和体内实验证实了Man-TEM用于鼻内免疫的潜在佐剂能力。在体外使用APC进行的机制研究中,我们发现Man-TEM通过刺激APC的MR受体增强了受体介导的内吞作用。由于Man-TEM中的甘露聚糖对APC的MR具有特异性识别作用,因此在小鼠中用负载OVA的Man-TEM进行鼻腔疫苗接种显示出血清IgG和黏膜sIgA水平高于可溶性OVA组。这些结果表明,黏附性和Man-TEM可能是用于引发全身和黏膜免疫的鼻腔疫苗递送系统的有前景的候选者。